Suchergebnisse - "Davies, Jane C"

PubPharm (25)

1

A Phase 3, open-label, 96-week trial to study the safety, tolerability, and efficacy of tezacaftor/ivacaftor in children ≥ 6 years of age homozygous for F508del or heterozygous for F508del and a residual function CFTR variant

enthalten in: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society | 2022

von Sawicki, G. | Chilvers, M. | McNamara, J. | +10

2

An Update on CFTR Modulators as New Therapies for Cystic Fibrosis

enthalten in: Paediatric drugs | 2022

von King, J. | Nichols, A. | Bentley, S. | +2

3

Riociguat for the treatment of Phe508del homozygous adults with cystic fibrosis

enthalten in: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society | 2021

von Derichs, N. | Taylor-Cousar, J. | Davies, J. | +20

4

Long-term safety and efficacy of lumacaftor-ivacaftor therapy in children aged 6-11 years with cystic fibrosis homozygous for the F508del-CFTR mutation : a phase 3, open-label, extension study

enthalten in: The Lancet. Respiratory medicine | 2021

von Chilvers, M. | Davies, J. | Milla, C. | +5

ErratumIn: Lancet Respir Med. 2021 Apr;9(4):e38. - PMID 33607008

5

Cystic fibrosis

enthalten in: Lancet (London, England) | 2021

von Shteinberg, M. | Haq, I. | Polineni, D. | +1

6

Cystic Fibrosis Lung Disease Modifiers and Their Relevance in the New Era of Precision Medicine

enthalten in: Genes | 2021

von Sepahzad, A. | Morris-Rosendahl, D. | Davies, J.

7

Ivacaftor in Infants Aged 4 to <12 Months with Cystic Fibrosis and a Gating Mutation. Results of a Two-Part Phase 3 Clinical Trial

enthalten in: American journal of respiratory and critical care medicine | 2021

von Davies, J. | Wainwright, C. | Sawicki, G. | +7

CommentIn: Am J Respir Crit Care Med. 2021 Mar 1;203(5):536-537. - PMID 33113333

8

Entering the era of highly effective modulator therapies

enthalten in: Pediatric pulmonology | 2021

von Dave, K. | Dobra, R. | Scott, S. | +4

9

Monitoring early stage lung disease in cystic fibrosis

enthalten in: Current opinion in pulmonary medicine | 2020

von Nissenbaum, C. | Davies, G. | Horsley, A. | +1

10

Gene Therapy for Respiratory Diseases : Progress and a Changing Context

enthalten in: Human gene therapy | 2020

von Alton, E. | Boyd, A. | Davies, J. | +5